Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alejandro Navarro

Showing results (91-100 of 101) with videos related to

Pageof 11
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 3, 2017
Deleterious Germline Mutations in Patients With Apparently Sporadic Pancreatic AdenocarcinomaKoji Shindo, Jun Yu, Masaya Suenaga, et al.
The New England Journal of Medicine|September 13, 2024
Durvalumab after Chemoradiotherapy in Limited-Stage Small-Cell Lung CancerYing Cheng, David R Spigel, Byoung Chul Cho, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2017
Genomic Profiling of Patient-Derived Xenografts for Lung Cancer Identifies <i>B2M</i> Inactivation Impairing ImmunorecognitionCarolina Pereira, Pol Gimenez-Xavier, Eva Pros, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 8, 2021
Nivolumab and Ipilimumab as Maintenance Therapy in Extensive-Disease Small-Cell Lung Cancer: CheckMate 451Taofeek K Owonikoko, Keunchil Park, Ramaswamy Govindan, et al.
Therapeutic Advances in Medical Oncology|June 30, 2025
Frequency of driver oncogenic alterations in NSCLC and estimated indoor radon exposure in Europe (RADON EUROPE study)Miguel García-Pardo, Marta García de Herreros, Edouard Auclin, et al.
Small (Weinheim an Der Bergstrasse, Germany)|July 24, 2025
Ribbons of Light: Emerging (Sb,Bi)(S,Se)(Br,I) Van der Waals Chalcohalides for Next-Generation Energy ApplicationsIvan Caño, Alejandro Navarro-Güell, Edoardo Maggi, et al.
International Journal of Cardiology. Congenital Heart Disease|December 23, 2024
Comparison in the adult congenital heart disease severity classification of ACC/AHA and ESC guidelines in a 3,459 Mexican populationEdgar García-Cruz, Montserrat Villalobos-Pedroza, Neftali Eduardo Antonio-Villa, et al.
The Lancet. Respiratory Medicine|October 17, 2022
Combination lurbinectedin and doxorubicin versus physician's choice of chemotherapy in patients with relapsed small-cell lung cancer (ATLANTIS): a multicentre, randomised, open-label, phase 3 trialSantiago Ponce Aix, Tudor Eliade Ciuleanu, Alejandro Navarro, et al.
Nature Communications|November 26, 2024
Soil carbon in the world's tidal marshesTania L Maxwell, Mark D Spalding, Daniel A Friess, et al.
JACC. Advances|June 28, 2024
Cardiometabolic Risk Factors in Mexican Adults With Congenital Heart DiseaseEdgar García-Cruz, Daniel Manzur-Sandoval, Rodrigo Gopar-Nieto, et al.
Pageof 11

Showing results (91-100 of 101) with videos related to

Sort By:
Pageof 11
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 3, 2017
Deleterious Germline Mutations in Patients With Apparently Sporadic Pancreatic AdenocarcinomaKoji Shindo, Jun Yu, Masaya Suenaga, et al.
The New England Journal of Medicine|September 13, 2024
Durvalumab after Chemoradiotherapy in Limited-Stage Small-Cell Lung CancerYing Cheng, David R Spigel, Byoung Chul Cho, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2017
Genomic Profiling of Patient-Derived Xenografts for Lung Cancer Identifies <i>B2M</i> Inactivation Impairing ImmunorecognitionCarolina Pereira, Pol Gimenez-Xavier, Eva Pros, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 8, 2021
Nivolumab and Ipilimumab as Maintenance Therapy in Extensive-Disease Small-Cell Lung Cancer: CheckMate 451Taofeek K Owonikoko, Keunchil Park, Ramaswamy Govindan, et al.
Therapeutic Advances in Medical Oncology|June 30, 2025
Frequency of driver oncogenic alterations in NSCLC and estimated indoor radon exposure in Europe (RADON EUROPE study)Miguel García-Pardo, Marta García de Herreros, Edouard Auclin, et al.
Small (Weinheim an Der Bergstrasse, Germany)|July 24, 2025
Ribbons of Light: Emerging (Sb,Bi)(S,Se)(Br,I) Van der Waals Chalcohalides for Next-Generation Energy ApplicationsIvan Caño, Alejandro Navarro-Güell, Edoardo Maggi, et al.
International Journal of Cardiology. Congenital Heart Disease|December 23, 2024
Comparison in the adult congenital heart disease severity classification of ACC/AHA and ESC guidelines in a 3,459 Mexican populationEdgar García-Cruz, Montserrat Villalobos-Pedroza, Neftali Eduardo Antonio-Villa, et al.
The Lancet. Respiratory Medicine|October 17, 2022
Combination lurbinectedin and doxorubicin versus physician's choice of chemotherapy in patients with relapsed small-cell lung cancer (ATLANTIS): a multicentre, randomised, open-label, phase 3 trialSantiago Ponce Aix, Tudor Eliade Ciuleanu, Alejandro Navarro, et al.
Nature Communications|November 26, 2024
Soil carbon in the world's tidal marshesTania L Maxwell, Mark D Spalding, Daniel A Friess, et al.
JACC. Advances|June 28, 2024
Cardiometabolic Risk Factors in Mexican Adults With Congenital Heart DiseaseEdgar García-Cruz, Daniel Manzur-Sandoval, Rodrigo Gopar-Nieto, et al.
Pageof 11